Edition:
United States

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

7.04CNY
1:59am EST
Change (% chg)

¥0.05 (+0.72%)
Prev Close
¥6.99
Open
¥6.99
Day's High
¥7.07
Day's Low
¥6.99
Volume
5,414,859
Avg. Vol
15,128,607
52-wk High
¥7.90
52-wk Low
¥6.00

Select another date:

Mon, Nov 7 2016

BRIEF-Zhejiang CONBA Pharmaceutical unit gets nod for clinic trial

* Says its unit gets China Food and Drug Administration's approval for clinic trial of a drug for preventing thrombus of atherosclerosis and acute coronary artery syndrome

BRIEF-Zhejiang Conba Pharma's 9-month net profit down 26.8 pct

Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Zhejiang Conba Pharmaceutical issues 1.1 bln yuan 5-YR bonds

* Says it issues 1.1 billion yuan worth bonds, with coupon rate at 3.17 percent

BRIEF-Zhejiang Conba Pharmaceutical to issue 1.1 bln yuan 5-yr bonds

* Says to issue 1.1 billion yuan ($164.89 million) 5-year bonds

BRIEF-Zhejiang Conba Pharmaceutical unit gets clinical trial approval for Anidulafungin Anidulafungin for injection

* Says its subsidiary Jinhua Kang'enbei Biology Pharmacy got clinical trial approval for Anidulafungin Anidulafungin for injection

BRIEF-Zhejiang CONBA Pharmaceutical to fully acquire Inner Mongolia unit for 50 mln yuan

* Says it will acquire 12 percent stake in its Inner Mongolia pharmaceutical unit for 50 million yuan

BRIEF-Zhejiang Conba Pharmaceutical unit gets nod for clinic trial

Aug 12 Zhejiang Conba Pharmaceutical Co., Ltd. :

BRIEF-Zhejiang Conba Pharma to invest further in online health service firm

* Says it plans to invest 146 million yuan ($21.96 million) in online health service firm for another 8 percent stake, bringing its holdings to 20 percent

Select another date: